Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN for Prophylaxis against transplant rejection: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 780 adverse event reports in the FDA FAERS database where LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN was used for Prophylaxis against transplant rejection.

Most Reported Side Effects for LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN

Side Effect Reports % Deaths Hosp.
Off label use 1,231 13.3% 371 342
Pyrexia 865 9.3% 217 456
Drug ineffective 662 7.1% 197 240
Product use in unapproved indication 648 7.0% 174 104
Cytomegalovirus infection 615 6.6% 167 196
Cytomegalovirus infection reactivation 484 5.2% 103 166
Post transplant lymphoproliferative disorder 439 4.7% 214 119
Transplant rejection 437 4.7% 41 130
Multiple organ dysfunction syndrome 379 4.1% 343 143
Sepsis 375 4.0% 242 158
Acute kidney injury 370 4.0% 142 228
Pneumonia 368 4.0% 155 152
Cytomegalovirus viraemia 359 3.9% 64 123
Bk virus infection 356 3.8% 100 200
Neutropenia 338 3.6% 102 109

Other Indications for LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN

Bone marrow conditioning regimen (1,884) Immunosuppressant drug therapy (1,597) Prophylaxis against graft versus host disease (808) Immunosuppression (789) Renal transplant (622) Allogenic stem cell transplantation (539) Stem cell transplant (442) Aplastic anaemia (421) Product used for unknown indication (356) Transplant rejection (273)

Other Drugs Used for Prophylaxis against transplant rejection

TACROLIMUS (7,852) MYCOPHENOLATE MOFETIL (6,062) PREDNISONE (2,470) CYCLOSPORINE (1,884) PREDNISOLONE (1,418) METHYLPREDNISOLONE (1,274) RITUXIMAB (970) MYCOPHENOLATE MOFETIL\MYCOPHENOLATE MOFETIL (954) BASILIXIMAB (883) EVEROLIMUS (862)

Related Pages

LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN Full Profile All Prophylaxis against transplant rejection Drugs LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN Demographics LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN Timeline